These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 13912256)

  • 21. Monoamine oxidases: versatility of catalytic properties and possible biological functions.
    Gorkin VZ
    Adv Pharmacol Chemother; 1973; 11():1-50. PubMed ID: 4201892
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 23. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide.
    DEWHURST WG; PARE CM
    J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403
    [No Abstract]   [Full Text] [Related]  

  • 24. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
    Baker GB; Sowa B; Todd KG
    J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolism of adrenaline after blockade of monoamine oxidase and catechol-O-methyltransferase.
    DE SCHAEPDRYVER AF; KIRSHNER N
    Science; 1961 Feb; 133(3452):586-7. PubMed ID: 13720844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ACTION OF SULFONAMIDOPHENYLHYDRAZINES ON MONOAMINE OXIDASE AND DIAMINOXIDASE].
    LESPAGNOL A; BAR D; OSTEUX R; ROBELET A; MIZON-CAPRON C
    Ann Pharm Fr; 1964; 22():417-28. PubMed ID: 14191784
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison of the amine oxidase-inhibiting and hypotensive effects of hydrazinophthalazines].
    SCHULER W; MEIER R
    Helv Physiol Pharmacol Acta; 1955; 13(2):106-12. PubMed ID: 13262685
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of monamine oxidase inhibitors on qualitive alterations ( Transformation ) of the catalytic properties of amine oxidases.
    Gorkin VZ; Akopyan ZI; Veryovkina IV; Stesina LN; Samed MM
    Biochem J; 1971 Feb; 121(3):31P-32P. PubMed ID: 5000918
    [No Abstract]   [Full Text] [Related]  

  • 29. [Characteristics of changes in amine oxidase activity during pesticide poisoning].
    Zeĭnalov TA; Gorkin VZ
    Vopr Med Khim; 1990; 36(1):78-81. PubMed ID: 2343583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The significance of amine oxidases in pathological states].
    Gorkin VZ
    Patol Fiziol Eksp Ter; 1988; (2):89-92. PubMed ID: 3137516
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism of acetylpolyamines by monoamine oxidase, diamine oxidase and polyamine oxidase.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y
    Biochim Biophys Acta; 1981 Oct; 677(2):190-3. PubMed ID: 6794648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monoamine liberators and monoamine oxidase inhibitors].
    LEUSEN I
    Psychiatr Neurol (Basel); 1960 Jul; 140():154-64. PubMed ID: 13761295
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoamine- and diamine oxidase activities in psoriasis.
    Ionescu G; Kiehl R
    Acta Derm Venereol; 1989; 69(3):264-5. PubMed ID: 2566240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of diamine oxidase in vivo by hydrazine derivatives.
    BURKARD WP; GEY KF; PLETSCHER A
    Biochem Pharmacol; 1960 Jul; 3():249-55. PubMed ID: 13806127
    [No Abstract]   [Full Text] [Related]  

  • 35. Glutamate - oxaloacetate transaminase, Monoamine oxidase, diamine oxidase and mixed function oxidase activities in rat liver after portacaval shunt.
    Buffoni F; Ignesti G; Pirisino R; Cortesini C
    Pharmacol Res Commun; 1982 Oct; 14(9):771-7. PubMed ID: 6817351
    [No Abstract]   [Full Text] [Related]  

  • 36. Temporary suppression of diamine oxidase (histaminase) activity by cysteamine.
    DE MARCO C; MONDOVI B; CAVALLINID
    Biochem Pharmacol; 1962 Jul; 11():509-14. PubMed ID: 13884364
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A; Todd KG; Baker GB
    Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of the monoamine oxidase and the diamine oxidase activity of a single blood sample].
    Sivoraksha GA; Sidel'nikov IuN
    Lab Delo; 1991; (2):51-4. PubMed ID: 1709989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience in treatment of over 2000 cases with amine oxidase inhibitors.
    SCHERBEL AL
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():67-9. PubMed ID: 13856328
    [No Abstract]   [Full Text] [Related]  

  • 40. The amine oxidases of mammalian blood plasma.
    BLASCHKO H
    Adv Comp Physiol Biochem; 1962; 1():67-116. PubMed ID: 13971522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.